ENXTPA:EXENSAerospace & Defense
Assessing Exosens (ENXTPA:EXENS) Valuation After Strong 2025 Results And New Growth Contracts
Exosens (ENXTPA:EXENS) is back in the spotlight after reporting 2025 sales of €468.2 million and net income of €42.7 million, alongside new 2026 revenue guidance and a proposed €0.30 per share dividend.
See our latest analysis for Exosens.
The latest earnings beat, new 2026 revenue guidance and the proposed €0.30 dividend appear to be feeding into strong momentum, with a 30 day share price return of 15.99% and a 1 year total shareholder return of 151.14% at a €62.4 share price.
If this kind...